The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Mechanisms of Insulin Resistance in Primary and Secondary Nonalcoholic Fatty Liver
Open accessAbstract
Nonalcoholic fatty liver disease is associated with hepatic insulin resistance and may result primarily from increased hepatic de novo lipogenesis (PRIM) or secondarily from adipose tissue lipolysis (SEC). We studied mice with hepatocyte- or adipocyte-specific SREBP-1c overexpression as models of PRIM and SEC. PRIM mice featured increased lipogenic gene expression in the liver and adipose tissue. Their selective, liver-specific insulin resistance was associated with increased C18:1-diacylglycerol content and protein kinase Cε translocation. SEC mice had decreased lipogenesis mediated by hepatic cholesterol responsive element–binding protein and featured portal/lobular inflammation along with total, whole-body insulin resistance. Hepatic mitochondrial respiration transiently increased and declined with aging along with higher muscle reactive oxygen species production. In conclusion, hepatic insulin resistance originates from lipotoxicity but not from lower mitochondrial capacity, which can even transiently adapt to increased peripheral lipolysis. Peripheral insulin resistance is prevented during increased hepatic lipogenesis only if adipose tissue lipid storage capacity is preserved.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Of note, IR in these two different models with MASLD can result not from impaired mitochondrial function but from increased accumulation of specific DAG [84].”
From Hepatic Insulin Resistance and Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: New Insights into Mechanisms and Clinical Implications (2025) · cites this paper as [84]
In the citing paper
“This is in line with the results from some studies in that hepatic esterification of FAs into TG, unlike DNL, depends on substrate delivery rather than insulin action [84-86].”
From Hepatic Insulin Resistance and Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: New Insights into Mechanisms and Clinical Implications (2025) · cites this paper as [84]
In the citing paper
“Actually, impaired mitochondrial function (i.e., decreased oxidative capacity and/or increased oxidative stress) did not precede IR.”
From Hepatic Insulin Resistance and Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: New Insights into Mechanisms and Clinical Implications (2025) · cites this paper as [84]
In the citing paper
“While this mechanism is important in the initial stages, the progression of MASLD ultimately depends on the development of total hepatic IR and systemic IR [84].”
From Hepatic Insulin Resistance and Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: New Insights into Mechanisms and Clinical Implications (2025) · cites this paper as [84]
In the citing paper
“However, augmented FA flux to the liver and/or peripheral IR may lead to so-called ‘secondary MASLD’ and total hepatic IR [84].”
From Hepatic Insulin Resistance and Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: New Insights into Mechanisms and Clinical Implications (2025) · cites this paper as [84]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
(2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.11.004 · Cited by 4,836
Donnelly, K. L., Smith, C. I., Schwarzenberg, S. J., Jessurun, J., Boldt, M. D., & Parks, E. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23621 · Cited by 3,604
Assessing mitochondrial dysfunction in cells
Brand, M. D., & Nicholls, D. G. (2011) · Biochemical Journal · doi:10.1042/bj20110162 · Cited by 2,436
INFLUENCES OF GLUCOSE LOADING AND OF INJECTED INSULIN ON HEPATIC GLUCOSE OUTPUT*
Steele, R. D. (1959) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1959.tb44923.x · Cited by 1,680
The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux
Samuel, V. T., & Shulman, G. I. (2016) · Journal of Clinical Investigation · doi:10.1172/jci77812 · Cited by 1,484
Self-citationMechanism of hepatic insulin resistance in non-alcoholic fatty liver disease
Samuel, V. T., Liu, Z.-X., Qu, X., Elder, B. D., Bilz, S., Befroy, D., Romanelli, A. J., & Shulman, G. I. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313478200 · Cited by 1,322
Self-citationEctopic Fat in Insulin Resistance, Dyslipidemia, and Cardiometabolic Disease
Shulman, G. I. (2014) · New England Journal of Medicine · doi:10.1056/nejmra1011035 · Cited by 1,126
Self-citationLambert, J. E., Ramos–Roman, M. A., Browning, J. D., & Parks, E. J. (2014) · Gastroenterology · doi:10.1053/j.gastro.2013.11.049 · Cited by 1,069 · cited 1×
“Although a feature of human NAFL (6), hepatic DNL does not necessarily lead to IR (7).”
BackgroundLeptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy
Shimomura, I., Hammer, R. E., Ikemoto, S., Brown, M. S., & Goldstein, J. L. (1999) · Nature · doi:10.1038/43448 · Cited by 1,038
Koliaki, C., Szendroedi, J., Kaul, K., Jelenik, T., Nowotny, P., Jankowiak, F., Herder, C., Carstensen, M., Krausch, M., Knoefel, W. T., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.04.004 · Cited by 1,032
Self-citation
Cited by
Sorted by citations
Mechanisms of Insulin Action and Insulin Resistance
Petersen, M. C., & Shulman, G. I. (2018) · Physiological Reviews · doi:10.1152/physrev.00063.2017 · Cited by 3,028
Self-citationThe complex link between NAFLD and type 2 diabetes mellitus - mechanisms and treatments
Targher, G., Corey, K. E., Byrne, C. D., & Roden, M. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00448-y · Cited by 850
Self-citationMitochondrial alterations in fatty liver diseases
Fromenty, B., & Roden, M. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.09.020 · Cited by 448
Self-citationKumar, S., Duan, Q., Wu, R., Harris, E. N., & Su, Q. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113869 · Cited by 382
Nonalcoholic fatty liver disease (NAFLD) from pathogenesis to treatment concepts in humans
Pafili, K., & Roden, M. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2020.101122 · Cited by 330
Self-citationInter-organ crosstalk during development and progression of type 2 diabetes mellitus
Xourafa, G., Korbmacher, M., & Roden, M. (2024) · Nature Reviews Endocrinology · doi:10.1038/s41574-023-00898-1 · Cited by 274
Self-citationMechanisms of muscle insulin resistance and the cross‐talk with liver and adipose tissue
Rosa, S. C. D. S., Nayak, N., Caymo, A. M., & Gordon, J. W. (2020) · Physiological Reports · doi:10.14814/phy2.14607 · Cited by 271
Integrative metabolism in MASLD and MASH: Pathophysiology and emerging mechanisms
Steinberg, G. R., Valvano, C. M., De Nardo, W., & Watt, M. J. (2025) · Journal of Hepatology · doi:10.1016/j.jhep.2025.02.033 · Cited by 240
Kumarendran, B., O’Reilly, M. W., Manolopoulos, K. N., Toulis, K. A., Gokhale, K. M., Sitch, A. J., Wijeyaratne, C. N., Coomarasamy, A., Arlt, W., & Nirantharakumar, K. (2018) · PLOS Medicine · doi:10.1371/journal.pmed.1002542 · Cited by 206
Interorgan Metabolic Crosstalk in Human Insulin Resistance
Gancheva, S., Jeleník, T., Álvarez-Hernández, E., & Roden, M. (2018) · Physiological Reviews · doi:10.1152/physrev.00015.2017 · Cited by 194
Self-citationHepatic glucose metabolism in the steatotic liver
Scoditti, E., Sabatini, S., Carli, F., & Gastaldelli, A. (2024) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-023-00888-8 · Cited by 134
Xia, M., Bian, H., & Gao, X. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00877 · Cited by 139
Targeting Metabolism, Insulin Resistance, and Diabetes to Treat Nonalcoholic Steatohepatitis
Finck, B. N. (2018) · Diabetes · doi:10.2337/dbi18-0024 · Cited by 125
Direct and indirect control of hepatic glucose production by insulin
Lewis, G. F., Carpentier, A. C., Pereira, S., Hahn, M., & Giacca, A. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.03.007 · Cited by 138
In Vitro and In Vivo Models of Non-Alcoholic Fatty Liver Disease: A Critical Appraisal
Soret, P.-A., Magusto, J., Housset, C., & Gautheron, J. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm10010036 · Cited by 121
Positive Effects of Physical Activity on Insulin Signaling
Małkowska, P. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb46060327 · Cited by 126
Metabolic Stress, Autophagy, and Cardiovascular Aging: from Pathophysiology to Therapeutics
Ren, J. T., Sowers, J. R., & Zhang, Y. (2018) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2018.08.001 · Cited by 101
Kanda, T., Goto, T., Hirotsu, Y., Masuzaki, R., Moriyama, M., & Omata, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041525 · Cited by 97
Insulin Resistance in Type 1 Diabetes: Pathophysiological, Clinical, and Therapeutic Relevance
Apostolopoulou, M., Lambadiari, V., Roden, M., & Dimitriadis, G. D. (2025) · Endocrine Reviews · doi:10.1210/endrev/bnae032 · Cited by 90
Self-citationTruong, X. T., & Lee, D. H. (2025) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2025.0644 · Cited by 84
“In a mouse model with hepatocyte-specific SREBP1c over-expression, SREBP1c targets specific genes and key enzymes in DNL and lipid metabolism to be upregulated with a characteristic liver-specific IR without peripheral IR in skeletal muscle [84].”
InfluentialDynamic changes of muscle insulin sensitivity after metabolic surgery
Gancheva, S., Ouni, M., Jeleník, T., Koliaki, C. C., Szendroedi, J., Toledo, F. G. S., Markgraf, D. F., Pesta, D. H., Mastrototaro, L., Filippo, E. D., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12081-0 · Cited by 78
Self-citationSmall, L., Brandon, A. E., Turner, N., & Cooney, G. J. (2018) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00337.2017 · Cited by 72
Preuss, C., Jeleník, T., Bódis, K. B., Müssig, K., Burkart, V., Szendroedi, J., Roden, M., & Markgraf, D. F. (2019) · Cells · doi:10.3390/cells8030277 · Cited by 74
Self-citationKang, S., Moon, M. K., Kim, W. K., & Koo, B. K. (2020) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12598 · Cited by 65
Zhang, C., Zhou, B.-G., Sheng, J., Chen, Y., Cao, Y.-Q., & Chen, C. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104984 · Cited by 66
Insulin Resistance and NAFLD: A Dangerous Liaison beyond the Genetics
Manco, M. (2017) · Children · doi:10.3390/children4080074 · Cited by 45
Mitochondrial role in the neonatal predisposition to developing nonalcoholic fatty liver disease
Baker, P. R., & Friedman, J. E. (2018) · Journal of Clinical Investigation · doi:10.1172/jci120846 · Cited by 64
Zheng, Z., Xu, Y.-Y., Liu, W., Zhang, Y., Zhang, C., Liu, H.-L., Zhang, X., Liu, R., Zhang, Y., Shi, M.-Y., et al. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2022.11.012 · Cited by 61
Guerra, S., Mocciaro, G., & Gastaldelli, A. (2021) · European Journal of Clinical Investigation · doi:10.1111/eci.13695 · Cited by 61
Gancheva, S., Kahl, S., Pesta, D., Mastrototaro, L., Dewidar, B., Strassburger, K., Sabah, E., Esposito, I., Weiß, J., Sarabhai, T., et al. (2022) · Diabetes Care · doi:10.2337/dc21-1758 · Cited by 60
Self-citationInsulin Resistance and Vulnerability to Cardiac Ischemia
Jeleník, T., Flögel, U., Álvarez-Hernández, E., Scheiber, D., Zweck, E., Ding, Z., Rothe, M., Mastrototaro, L., Kohlhaas, V., Kotzka, J., et al. (2018) · Diabetes · doi:10.2337/db18-0449 · Cited by 58
Self-citationDewidar, B., Mastrototaro, L., Englisch, C., Ress, C., Granata, C., Rohbeck, E., Pesta, D. H., Heilmann, G., Wolkersdorfer, M. F., Esposito, I., et al. (2023) · EBioMedicine · doi:10.1016/j.ebiom.2023.104714 · Cited by 57
Self-citationMichalopoulou, E., Thymis, J., Lampsas, S., Pavlidis, G., Katogiannis, K., Vlachomitros, D., Katsanaki, E., Kostelli, G., Pililis, S., Pliouta, L., et al. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14020428 · Cited by 69
Diabetes as a risk factor for MASH progression
Gancheva, S., Roden, M., & Castéra, L. (2024) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2024.111846 · Cited by 60
Self-citationMuscle Loss in Chronic Liver Diseases: The Example of Nonalcoholic Liver Disease
Bandt, J. P. D., Jegatheesan, P., & El-Hafaia, N. (2018) · Nutrients · doi:10.3390/nu10091195 · Cited by 51
Shabgah, A. G., Norouzi, F., Hedayati‐Moghadam, M., Soleimani, D., Pahlavani, N., & Navashenaq, J. G. (2021) · Nutrition & Metabolism · doi:10.1186/s12986-021-00552-5 · Cited by 49
Hörbelt, T., Tacke, C., Markova, M., de Wiza, D. H., de Velde, F. V., Bekaert, M., Nieuwenhove, Y. V., Hornemann, S., Rödiger, M., Seebeck, N., et al. (2018) · Diabetologia · doi:10.1007/s00125-018-4636-9 · Cited by 49
Self-citationWesolowski, S. R., Mulligan, C. M., Janssen, R. C., Baker, P. R., Bergman, B. C., D’Alessandro, A., Nemkov, T. G., Maclean, K. N., Jiang, H., Dean, T. A., et al. (2018) · Molecular Metabolism · doi:10.1016/j.molmet.2018.09.008 · Cited by 48
Liu, H., Chen, T., Xie, X., Wang, X., Luo, Y., Xu, N., Sa, Z., Zhang, M., Chen, Z., Hu, X., et al. (2021) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.1c03379 · Cited by 45
The adipokine sFRP4 induces insulin resistance and lipogenesis in the liver
Hörbelt, T., Knebel, B., Fahlbusch, P., Barbosa, D., de Wiza, D. H., de Velde, F. V., Nieuwenhove, Y. V., Lapauw, B., Thoresen, G. H., Al‐Hasani, H., et al. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2019.07.008 · Cited by 47
Self-citationPNPLA3-I148M: a problem of plenty in non-alcoholic fatty liver disease
Ray, S. B. (2019) · Adipocyte · doi:10.1080/21623945.2019.1607423 · Cited by 50
Hong, S., Sung, Y., Hong, Y. S., Song, D. K., Jung, H., Jeong, K., Chung, H., & Lee, H. (2023) · Scientific Reports · doi:10.1038/s41598-023-39428-4 · Cited by 44
Merrill, M. A. L., Johnson, C. L., Smith, M. T., Kandula, N. R., Macherone, A., Pennell, K. D., & Kanaya, A. M. (2019) · Environmental Science & Technology · doi:10.1021/acs.est.9b03373 · Cited by 46
Understanding the association of polycystic ovary syndrome and non-alcoholic fatty liver disease
Salva-Pastor, N., Chávez-Tapia, N. C., Uribe, M., & Nuño‐Lámbarri, N. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.105445 · Cited by 44
Fatty Liver Due to Increased de novo Lipogenesis: Alterations in the Hepatic Peroxisomal Proteome
Knebel, B., Fahlbusch, P., Dille, M. A., Wahlers, N., Hartwig, S., Jacob, S., Kettel, U., Schiller, M., Herebıan, D., Koellmer, C., et al. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00248 · Cited by 44
Self-citationHepatic dysfunction after spinal cord injury: A vicious cycle of central and peripheral pathology?
Goodus, M. T., & McTigue, D. M. (2019) · Experimental Neurology · doi:10.1016/j.expneurol.2019.113160 · Cited by 47
Wu, C., Xiang, S., Wang, H., Zhang, X., Tian, X., Tan, M., & Su, W. (2024) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.3c18029 · Cited by 43
Nguyen, P., Valanejad, L., Cast, A. E., Wright, M., Garcia, J. M., El‐Serag, H. B., Karns, R. A., & Timchenko, N. A. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.07.014 · Cited by 43
Lee, S., Han, D., Kang, H., Jeong, S. J., Jo, J.-E., Shin, J., Kim, D. K., & Park, H. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.01.008 · Cited by 41
Frankó, A., Merkel, D., Kovářová, M., Hoene, M., Jaghutriz, B. A., Heni, M., Königsrainer, A., Papan, C., Lehr, S., Häring, H., et al. (2018) · Nutrients · doi:10.3390/nu10091314 · Cited by 41
Self-citationFahlbusch, P., Knebel, B., Hörbelt, T., Barbosa, D. M., Nikolic, A., Jacob, S., Al‐Hasani, H., de Velde, F. V., Nieuwenhove, Y. V., Müller‐Wieland, D., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21114144 · Cited by 40
Self-citationTreating Hepatic Steatosis and Fibrosis by Modulating Mitochondrial Pyruvate Metabolism
McCommis, K. S., & Finck, B. N. (2019) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2018.09.017 · Cited by 39
Jung, Y., Lee, M. K., Puri, P., Koo, B. K., Joo, S. K., Jang, S. Y., Lee, D. H., Jung, Y. J., Kim, B. G., Lee, K. L., et al. (2020) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.16066 · Cited by 39
Lipodystrophies—Disorders of the Fatty Tissue
Knebel, B., Müller-Wieland, D., & Kotzka, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228778 · Cited by 39
Self-citationDPP4 deletion in adipose tissue improves hepatic insulin sensitivity in diet-induced obesity
Romacho, T., Sell, H., Indrakusuma, I., Röhrborn, D., Castañeda, T. R., Jeleník, T., Markgraf, D. F., Hartwig, S., Weiß, J., Al‐Hasani, H., et al. (2019) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00323.2019 · Cited by 37
Self-citationCortés, V., Quezada, N., Uribe, S. A., Arrese, M. A., & Nervi, F. O. (2017) · Lipids in Health and Disease · doi:10.1186/s12944-017-0525-3 · Cited by 37
Zhu, S., Wang, Y., Luo, F., Liu, J., Xiu, L., Qin, J., Wang, T., Yu, N. H., Wu, H., & Zou, T. (2019) · BioMed Research International · doi:10.1155/2019/7643542 · Cited by 35
The role of anti-diabetic drugs in NAFLD. Have we found the Holy Grail? A narrative review
Zachou, M., Flevari, P., Ansari, N. N., Varytimiadis, C., Kalaitzakis, E., Kassi, E. N., & Ανδρουτσάκος, Θ. (2023) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-023-03586-1 · Cited by 38
Angiotensinogen in Hepatocytes Contributes to Western Diet-Induced Liver Steatosis
Tao, X., Rong, J., Lu, H. S., Daugherty, A., Shi, P. D., Ke, C., Zhang, Z., Xu, Y., & Wang, J.-A. (2019) · Journal of Lipid Research · doi:10.1194/jlr.m093252 · Cited by 33
Nardo, A. D., Grün, N. G., Zeyda, M., Dumanic, M., Oberhuber, G., Rivelles, E., Helbich, T. H., Markgraf, D. F., Roden, M., Claudel, T., et al. (2020) · Liver International · doi:10.1111/liv.14464 · Cited by 31
Self-citationNonalcoholic fatty liver disease and obstructive sleep apnea in women with polycystic ovary syndrome
Doycheva, I., & Ehrmann, D. A. (2022) · Fertility and Sterility · doi:10.1016/j.fertnstert.2022.03.020 · Cited by 33
Drygalski, K., Siewko, K., Chomentowski, A., Odrzygóźdź, C., Zalewska, A., Kretowski, A. J., & Maciejczyk, M. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/8872702 · Cited by 29
Wade, H., Pan, K., Zhang, B., Zheng, W., & Su, Q. (2024) · eGastroenterology · doi:10.1136/egastro-2024-100115 · Cited by 29
Helicobacter pylori infection aggravates diet-induced nonalcoholic fatty liver in mice
He, C., Cheng, D., Wang, H., Wu, K., Zhu, Y., & Lü, N. (2018) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2017.12.008 · Cited by 27
Scheiber, D., Jeleník, T., Zweck, E., Horn, P., Schultheiß, H., Laßner, D., Boeken, U., Saeed, D., Kelm, M., Roden, M., et al. (2019) · Experimental & Molecular Medicine · doi:10.1038/s12276-019-0214-6 · Cited by 26
Self-citationGonzález‐Villanueva, I., DeGracia, C., Planells, M., Poveda, I., Álvarez, P., Schneller‐Pavelescu, L., Betlloch, I., Jemec, G. B. E., Ramos, J. M., & Pascual, J. C. (2020) · Acta Dermato Venereologica · doi:10.2340/00015555-3597 · Cited by 26
Schyr, R. B., Al‐Kurd, A., Moalem, B., Permyakova, A., Israeli, H., Bardugo, A., Arad, Y., Hefetz, L., Bergel, M., Haran, A., et al. (2021) · Diabetes · doi:10.2337/db21-0251 · Cited by 26
FGF21 regulates insulin sensitivity following long-term chronic stress
Jeleník, T., Dille, M. A., Müller-Lühlhoff, S., Kabra, D. G., Zhou, Z., Binsch, C., Hartwig, S., Lehr, S., Chadt, A., Peters, E. M. J., et al. (2018) · Molecular Metabolism · doi:10.1016/j.molmet.2018.06.012 · Cited by 26
Self-citationExercise decreases CLK2 in the liver of obese mice and prevents hepatic fat accumulation
Muñoz, V. R., Gaspar, R. C., Kuga, G. K., Nakandakari, S. C. B. R., Baptista, I. L., Mekary, R. A., da Silva, A. S. R., de Moura, L. P., Ropelle, E. R., Cintra, D. E., et al. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26780 · Cited by 25
Key, C.-C. C., Bishop, A. C., Wang, X., Zhao, Q., Chen, G., Quinn, M. A., Zhu, X., Zhang, Q., & Parks, J. S. (2020) · Journal of Lipid Research · doi:10.1194/jlr.ra120000760 · Cited by 22
Sun, C., Guo, Y., Cong, P., Tian, Y., & Gao, X. (2023) · Nutrients · doi:10.3390/nu15061359 · Cited by 27
Zhong, X., Ke, C., Cai, Z., Wu, H., Ye, Y., Liang, X., Yu, L., Jiang, S., Shen, J., Wang, L., et al. (2020) · Aging · doi:10.18632/aging.103658 · Cited by 23
Zhang, C., Chen, F., Li, F., Shan, Q., Zheng, G., Wang, Y., Lu, J. L., Fan, S., Sun, C., Wu, D., et al. (2019) · Molecular Medicine · doi:10.1186/s10020-019-0099-9 · Cited by 24
Sarabhai, T., Mastrototaro, L., KAHL, S., Bönhof, G. J., Jonuscheit, M., Bobrov, P., Katsuyama, H., Guthoff, R., Wolkersdorfer, M. F., Herder, C., et al. (2022) · Diabetologia · doi:10.1007/s00125-022-05797-0 · Cited by 22
Self-citationPersonnaz, J., Piccolo, E. B., Dortignac, A., Iacovoni, J. S., Mariette, J., Rocher, V., Polizzi, A., Batut, A., Deleruyelle, S., Bourdens, L., et al. (2022) · Science Advances · doi:10.1126/sciadv.abg9055 · Cited by 22
D-Pinitol Increases Insulin Secretion and Regulates Hepatic Lipid Metabolism in Msg-Obese Mice
JÚNIOR, J. A. D. S., SILVA, A. C. V. F. D., Figueiredo, L. S., Araújo, T. R., Freitas, I. N., Carneiro, E. M., Ribeiro, E. D. S., & Ribeiro, R. A. (2020) · Anais da Academia Brasileira de Ciências · doi:10.1590/0001-3765202020201382 · Cited by 20
Hepatic Mediators of Lipid Metabolism and Ketogenesis: Focus on Fatty Liver and Diabetes
Fernandes, G. W., & Bocco, B. M. L. C. (2020) · Current Diabetes Reviews · doi:10.2174/1573399816999201103141216 · Cited by 20
Manka, P. P., Kaya, E., Canbay, A. E., & Syn, W. (2021) · Digestive Diseases and Sciences · doi:10.1007/s10620-021-07206-9 · Cited by 22
Surugihalli, C., Porter, T. E., Chan, A., Farley, L. S., Maguire, M., Zhang, C., Kattapuram, N., Muyyarikkandy, M. S., Liu, H., & Sunny, N. E. (2019) · Scientific Reports · doi:10.1038/s41598-019-56715-1 · Cited by 20
Tracers and Imaging of Fatty Acid and Energy Metabolism of Human Adipose Tissues
Carpentier, A. C. (2023) · Physiology · doi:10.1152/physiol.00012.2023 · Cited by 22
Wang, R., Yan, R., Jiao, J., Li, F., Zhang, H., Chang, Z., Wei, H., Yan, S., & Li, J. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1398184 · Cited by 18
Natural compounds proposed for the management of non-alcoholic fatty liver disease
Merenda, T., Juszczak, F., Ferier, E., Duez, P., Patris, S., Declèves, A., & Nachtergael, A. (2024) · Natural Products and Bioprospecting · doi:10.1007/s13659-024-00445-z · Cited by 18
Binsch, C., Jeleník, T., Pfitzer, A., Dille, M. A., Müller-Lühlhoff, S., Hartwig, S., Karpinski, S., Lehr, S., Kabra, D. G., Chadt, A., et al. (2017) · Molecular Metabolism · doi:10.1016/j.molmet.2017.08.008 · Cited by 17
Self-citationSakamoto, Y., Oniki, K., Kumagae, N., Morita, K., Otake, K., Ogata, Y., & Saruwatari, J. (2019) · Disease Markers · doi:10.1155/2019/4065327 · Cited by 17
Long-term adjustment of hepatic lipid metabolism after chronic stress and the role of FGF21
Dille, M. A., Nikolic, A., Wahlers, N., Fahlbusch, P., Jacob, S., Hartwig, S., Lehr, S., Kabra, D. G., Klymenko, O., Al‐Hasani, H., et al. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2021.166286 · Cited by 16
Self-citationNudix hydrolase NUDT19 regulates mitochondrial function and ATP production in murine hepatocytes
Görigk, S., Ouwens, D. M., Kuhn, T., Altenhofen, D., Binsch, C., Damen, M., Khuong, J. M.-A., Kaiser, K., Knebel, B., Vogel, H., et al. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2022.159153 · Cited by 14
Self-citationLiu, R., Jin, Y., Liu, B., Zhang, Q., Li, X., Cai, D., Tian, L., Jiang, X., Zhang, W., Sun, J., et al. (2023) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.2c06849 · Cited by 15
DesOrmeaux, G. J., Petrick, H. L., Brunetta, H. S., & Holloway, G. P. (2021) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00610.2020 · Cited by 16
Intramyocellular Triglyceride Content During the Early Course of Type 1 and Type 2 Diabetes
Schön, M., Zaharia, O., Straßburger, K., Kupriyanova, Y., Bódis, K. B., Heilmann, G., Strom, A., Bönhof, G. J., MICHELOTTI, F. C., Yurchenko, I., et al. (2023) · Diabetes · doi:10.2337/db23-0353 · Cited by 14
Self-citationSyed‐Abdul, M. M., Moore, M. P., Wheeler, A. A., Ganga, R., Diaz‐Arias, A. A., Petroski, G. F., Rector, R. S., Ibdah, J. A., & Parks, E. J. (2023) · Journal of Nutrition · doi:10.1016/j.tjnut.2023.09.018 · Cited by 15
Moon, J., Jeon, J., Kong, E., Hong, S., Lee, J., Lee, E. K., & Kim, P. (2021) · Biomedical Optics Express · doi:10.1364/boe.442608 · Cited by 14
Surugihalli, C., Farley, L. S., Beckford, R. C., Kamkrathok, B., Liu, H., Muralidaran, V., Patel, K., Porter, T. E., & Sunny, N. E. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.870451 · Cited by 13
Mandala, A., Dobrinskikh, E., Janssen, R. C., Fiehn, O., D’Alessandro, A., Friedman, J. E., & Jonscher, K. R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23116043 · Cited by 13
Perspectives on diacylglycerol-induced improvement of insulin sensitivity in type 2 diabetes
Li, D., Zhu, Y., Wang, Y., Zou, Q., Duan, J., Sun‐Waterhouse, D., & Sun, B. (2021) · Food Science and Human Wellness · doi:10.1016/j.fshw.2021.11.004 · Cited by 13
Spradley, F. T., Smith, J. A., Alexander, B. T., & Anderson, C. D. (2018) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00394.2017 · Cited by 13
Li, H., Yoo, W., Park, H., Lim, S.-Y., Shin, D., Kim, S., Park, H.-Y., & Jeong, T. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092325 · Cited by 13
Eshraghian, A., Nikeghbalian, S., Shamsaeefar, A., Kazemi, K., Fattahi, M. R., & Malek‐Hosseini, S. A. (2020) · Scientific Reports · doi:10.1038/s41598-020-69571-1 · Cited by 13
Neuronal Lipoprotein Lipase Deficiency Alters Neuronal Function and Hepatic Metabolism
Bruce, K. D., Wang, H., Dobrinskikh, E., Rudenko, I. A., Gao, H., Libby, A. E., Gorkhali, S., Yu, T., Zsombok, A., & Eckel, R. H. (2020) · Metabolites · doi:10.3390/metabo10100385 · Cited by 11
Fahlbusch, P., Nikolic, A., Hartwig, S., Jacob, S., Kettel, U., Koellmer, C., Al‐Hasani, H., Lehr, S., Müller‐Wieland, D., Knebel, B., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23126873 · Cited by 11
Self-citationWollman, A., Daniel, T., & Rosenzweig, T. (2019) · Nutrients · doi:10.3390/nu11123044 · Cited by 10
Metadata
- Authors
- Jelenik, T., Kaul, K., Séquaris, G., Flögel, U., Phielix, E., Kotzka, J., Knebel, B., Fahlbusch, P., Hörbelt, T., Lehr, S., Reinbeck, A. L., Müller-Wieland, D., Esposito, I., Shulman, G. I., Szendroedi, J., & Roden, M.
- Affiliations
- Institute for Clinical Diabetology, German Diabetes Center, Düsseldorf, Germany
- Deutsches Diabetes-Zentrum e.V. (DE)
- Heinrich Heine University Düsseldorf (DE)
- Department of Internal Medicine I, University Hospital Aachen, Aachen, Germany
- Institute of Pathology, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany
- Howard Hughes Medical Institute (US)
- Corresponding author
- Roden, Michael
- ORCID
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2017-05-10
- Volume
- 66
- Issue
- 8
- Pages
- 2241-2253
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- PMC
- PMC5521856
- OpenAlex
- W2612023289
- Cited by
- 154
- References
- 58
- Citations by year
- 2026: 8 · 2025: 9 · 2024: 11 · 2023: 18 · 2022: 15 · 2021: 16 · 2020: 28 · 2019: 25 · 2018: 19 · 2017: 5
- FWCI
- 16.50
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Diabetes (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- RWTH Publications (RWTH Aachen) (submittedVersion)
- Funders
- Ministry of Science and Research of the State of North Rhine-Westphalia
- German Federal Ministry of Health
- Federal Ministry for Research
- German Center for Diabetes Research
- Helmholtz Alliance to Universities
- German Research Foundation (SFB 1116)
- German Diabetes Association
- Schmutzler-Stiftung
- National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases (R01-DK-40936, U24-DK-059635, P30-DK-45735)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Keywords
- insulin resistance, non-alcoholic fatty liver disease, hepatic de novo lipogenesis, adipose tissue lipolysis, SREBP-1c, lipotoxicity, mitochondrial respiration, reactive oxygen species, liver inflammation, aging
- MeSH terms
- Animals, Diglycerides, Female, Insulin Resistance, Lipolysis, Liver, Mice, Transgenic, Reactive Oxygen Species, Adipocytes, Protein Transport, Hepatocytes, Lipogenesis, Mice, Protein Kinase C-epsilon, Sterol Regulatory Element Binding Protein 1, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
